Health Professional Radio - Podcast

Walter Denton discusses his sarcoma diagnosis, Swim Across America, and how he and his family have taken a challenging situation and turned it into a family and community philanthropic effort. Read more: https://bit.ly/326ZPHD #FightCancer #FightSarcoma #SwimToFightCancer

Dr. Amanda Sheehan talks about Digital Smile Design, a software recently created in Brazil that allows the patient to see how their new smile can look through the use of photos, videos, and temporary mock-ups. Read more: https://bit.ly/2Zu141I #DigitalSmileDesign #DSD #NewSmileMockup

Gigi Sorenson, R.N., GlobalMed's Chief Clinical Officer and Vice President of Operations, discusses the benefits of telemedicine in pediatric care. #Telemedicine #PediatricCare #TelemedicineBenefits Visit our website www.healtprofessionalradio.com.au Follow us on our social media channels Facebook: https://www.facebook.com/hprfm/ Twitter: https://twitter.com/HealthProRadio Google+: https://plus.google.com/+HealthProfes... Pinterest: https://www.pinterest.com/HealthProRa... Linkedin: https://www.linkedin.com/company/heal... Instagram: https://www.instagram.com/healthprofe... Subscribe to our podcast channels Soundcloud: https://soundcloud.com/healthprofessi... Itunes: https://itunes.apple.com/nz/podcast/h... Support us on Patreon https://www.patreon.com/HPR

Dr. Scot Ebbinghaus from Merck Research Laboratories discusses the recent European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) positive opinion on Merck's KEYTRUDA® (pembrolizumab) in combination with Inlyta (axitinib) as first-line treatment for advanced renal cell carcinoma. Opinion granted based on data from the Phase 3 KEYNOTE-426 Trial. #RenalCellCarcinoma #AdvancedRenalCellCarcinoma #AdvancedRenalCellCarcinomaTreatment Visit our website www.healtprofessionalradio.com.au Follow us on our social media channels Facebook: https://www.facebook.com/hprfm/ Twitter: https://twitter.com/HealthProRadio Google+: https://plus.google.com/+HealthProfes... Pinterest: https://www.pinterest.com/HealthProRa... Linkedin: https://www.linkedin.com/company/heal... Instagram: https://www.instagram.com/healthprofe... Subscribe to our podcast channels Soundcloud: https://soundcloud.com/healthprofessi... Itunes: https://itunes.apple.com/nz/podcast/h... Support us on Patreon https://www.patreon.

Dr. Suela Sulo, a study author and health outcomes researcher at Abbott talks about the first-of-its-kind study published in the Journal of Parenteral and Enteral Nutrition, that followed more than 1,500 home healthcare patients for 90 days. The research shows that prioritizing nutrition care in patients at risk for malnutrition not only had a dramatic impact on keeping home health patients out of the hospital but also helped save millions in healthcare costs. #NutritionCare #Malnutrition #PrioritizeMalnutrition Visit our website www.healtprofessionalradio.com.au Follow us on our social media channels Facebook: https://www.facebook.com/hprfm/ Twitter: https://twitter.com/HealthProRadio Google+: https://plus.google.com/+HealthProfes... Pinterest: https://www.pinterest.com/HealthProRa... Linkedin: https://www.linkedin.com/company/heal... Instagram: https://www.instagram.com/healthprofe... Subscribe to our podcast channels Soundcloud: https://soundcloud.com/healthprofessi... Itunes: https://itunes.apple.com/

Dr. Darius Francescatti, a breast surgeon with Rush University Medical Center, discusses the latest technological advances designed to enhance the effectiveness of lumpectomy procedures, including the use of 3D tomography (Kubtec's Mozart System) in the operating room, and why the 20 percent average re-excision rate for the U.S. is too high.

Dr. Neal D. Shore discusses the recent (July 2019) FDA approval of Bayer's NUBEQA® (darolutamide) for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC). The approval is based on the Phase III ARAMIS trial, published earlier this year in the New England Journal of Medicine, the largest Phase III study in nmCRPC to date.

Jim Omel discusses his participation in the INSIGHT MM (multiple myeloma) Study of which he is also an author and the benefits of real-world evidence with patients participating in trials in multiple myeloma.

Dawn Marie Stull, scientific director and lead of global medical affairs at Takeda Oncology, discusses the INSIGHT MM (multiple myeloma) study, the largest pharmaceutical company-sponsored global observational study of its kind in multiple myeloma.

Shawn Singh, CEO of discusses their pipeline which includes nasal sprays that work like spritzers to the brain, for instance, PH10, an experimental antidepressant that completed a phase 2a study and received a patent, and PH94B, for Social Anxiety Disorder (SAD) that will soon enter Phase 3.

Dr Aswini Misro talks about building a free artificial intelligence application to reduce monopoly in healthcare and to educate the patient.

Dr Jeff Leighton, a professional pharmacologist, discusses the science behind the newly launched REVIVE, a non-caffeinated energy supplement.

Terri Milton discusses having nonalcoholic steatohepatitis (NASH) a chronic and progressive liver disease that occurs when excessive amounts of fat build up in the liver causing liver inflammation and damage. She is here to talk about her journey and help to raise awareness about NASH.

Dr. Christi Heck discusses drug resistant epilepsy, VNS therapy, and her work with Greg & Jake Grunberg who were on the show recently.

Dr. Gregg Sylvester, Vice President of Medical Affairs at Seqirus discusses their portfolio of influenza vaccines with the majority of doses coming from its adjuvanted and cell-based technology platforms. There is a range of options for children aged six months and older and the first-and-only adjuvanted seasonal influenza vaccine developed for people aged 65 and older.

Patrick Connor at AstraZeneca, discusses The Lung Ambition Alliance and their goal to double the 5-year survival rate and to one day eliminate lung cancer.

Alexis Brink, author of "THE ART OF JIN SHIN: The Japanese Practice of Healing with Your Fingertips" talks about her book, the practice of Jin Shin, and the benefits derived from it.

Dr. Regina Berkovich discusses the different types of MS and the new FDA approved drug Mayzent ® (siponimod) that is the first and only pill studied and proven in secondary progressive multiple sclerosis (SPMS). She is joined by Paula, a 52-year-old patient who has had MS for nearly 20 years and has been living with active SPMS for several years.

Dr. Nader Sanai, a neurosurgical oncologist, and the director of the non-profit Ivy Brain Tumor Center at Barrow Neurological Institute discusses attacking brain cancer from a completely new angle with an industry-first approach based on three key pillars: advanced genetic testing; micro-dosing; and combination therapies.

Dr. Ostad discusses cutaneous squamous cell carcinoma (CSCC) & the survey that showed that many people are not aware of this type of skin cancer.